Back

LLP2A_PartB

Official Title

Early Phase I Evaluation of 64Cu-LLP2A for Imaging Hematologic Malignancies Part B

Study Details

The primary purpose of this imaging research study is to test the safety and tolerability of an investigational PET imaging agent in healthy volunteers and patients with blood cancers (multiple myeloma and lymphoma)

Principal Investigator

Dr. Farrokh Dehdashti

IRB Number

202409162

Eligibility

1. Participants must be 18 years of age or older
2. Participants must be currently healthy
3. Participants must be able to lie still on their back within the PET/CT scanner for imaging

Compensation is provided (contact the study team for compensation amount).

This study accepts healthy volunteers.

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back